|
| |
| | | 58078 | | 20.12.2007 | | Novartis Pharma Schweiz AG | | | | | | | | | | | | | 01.99. | | | | 01.99. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Exelon Patch 5 | transdermales Pflaster | Transdermales Pflaster (Rivastigmin 9 mg) | N06DA03 | PI | | 02 | Exelon Patch 10 | transdermales Pflaster | Transdermales Pflaster (Rivastigmin 18 mg) | N06DA03 | PI | | 05 | Exelon Patch 15 | transdermales Pflaster | Transdermales Pflaster (Rivastigmin 27 mg) | N06DA03 | PI |
|
|
|
